Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Dermatitis
(1986): Hirata M+, Kokyu To Junkan (Japanese) 34, 791
Edema
(1995): Dark DS+, Infections in Medicine October, 551
Erythema multiforme
(2000): Ibia EO+, Arch Dermatol 136, 849
(1999): Joubert GI+, Can J Clin Pharmacol 6, 197 (17 cases)
(1988): Platt R+, JInfectDis158, 474 (0.6%)
(1985): Levine LR, Ped Infect Dis 4, 358 (0.6%)
(1982): Lovell SJ+, Can Med Assoc J 126, 1032
(1980): Murray DL+, NEnglJMed303, 1003
Exanthems
(2000): Ibia EO+, Arch Dermatol 136, 849
(1996): Nagayama H+, JDermatol23, 899
(1994): Litt JZ, Beachwood, OH (personal case) (observation)
(1994): Shelley WB+, Cutis 53, 40 (observation)
(1987): Norrby SR, Drugs 34 (Suppl 2), 105 (1–5%)
(1986): Ascher H, Lakartidningen (Swedish) 83, 411
(1985): Murray DL+, Pediatr Infect Dis 4, 706
(1983): Johnson T, JArkMedSoc80, 110
(1982): Lovell SJ+, Can Med Assoc J 126, 1032
(1981): Ackley AM+, Southern Med J 74, 1550
(1980): Murray DL+, NEnglJMed303, 1003
Fixed eruption
(2005): Aihara Y+, Pediatr Int 47(6), 616
Pruritus (